Analysen von Michael J. Yee
| 21.10.11 | Biogen outperform | RBC Capital Markets | |
| 20.10.11 | Cubist Pharmaceuticals outperform | RBC Capital Markets | |
| 18.10.11 | Acorda Therapeutics, outperform | RBC Capital Markets | |
| 17.10.11 | Dendreon sector perform | RBC Capital Markets | |
| 14.10.11 | Human Genome Sciences outperform | RBC Capital Markets | |
| 14.10.11 | Biogen outperform | RBC Capital Markets | |
| 13.10.11 | Elan outperform | RBC Capital Markets | |
| 13.10.11 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 06.10.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 06.10.11 | Amgen outperform | RBC Capital Markets | |
| 06.10.11 | Biogen outperform | RBC Capital Markets | |
| 06.10.11 | Celgene sector perform | RBC Capital Markets | |
| 06.10.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 04.10.11 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 29.09.11 | Biogen outperform | RBC Capital Markets | |
| 27.09.11 | ImmunoGen outperform | RBC Capital Markets | |
| 23.09.11 | Celgene sector perform | RBC Capital Markets | |
| 23.09.11 | SIGA Technologies outperform | RBC Capital Markets | |
| 22.09.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 21.09.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 14.09.11 | Amgen outperform | RBC Capital Markets | |
| 09.09.11 | Dendreon sector perform | RBC Capital Markets | |
| 09.09.11 | Human Genome Sciences outperform | RBC Capital Markets | |
| 09.09.11 | Dendreon sector perform | RBC Capital Markets | |
| 09.09.11 | Auxilium Pharmaceuticals sector perform | RBC Capital Markets | |
| 07.09.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 01.09.11 | Dendreon sector perform | RBC Capital Markets | |
| 29.08.11 | Biogen outperform | RBC Capital Markets | |
| 23.08.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 18.08.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 17.08.11 | Dendreon sector perform | RBC Capital Markets | |
| 11.08.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 11.08.11 | XenoPort outperform | RBC Capital Markets | |
| 11.08.11 | Xoma outperform | RBC Capital Markets | |
| 04.08.11 | Biogen outperform | RBC Capital Markets | |
| 29.07.11 | Dendreon outperform | RBC Capital Markets | |
| 28.07.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 22.07.11 | Regeneron Pharmaceuticals sector perform | RBC Capital Markets | |
| 22.07.11 | Allos Therapeutics sector perform | RBC Capital Markets | |
| 21.07.11 | Regeneron Pharmaceuticals sector perform | RBC Capital Markets | |
| 15.07.11 | Auxilium Pharmaceuticals sector perform | RBC Capital Markets | |
| 05.07.11 | Amgen outperform | RBC Capital Markets | |
| 14.06.11 | United Therapeutics sector perform | RBC Capital Markets | |
| 27.05.11 | Dendreon outperform | RBC Capital Markets | |
| 26.04.11 | Biogen outperform | RBC Capital Markets | |
| 25.02.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 28.02.11 | Biogen outperform | RBC Capital Markets | |
| 22.12.10 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |